Conclusion:
Minimizing flow artifact with echo time <5msec improves
accurate interpretation of true cerebrovascular disease and ensures
appropriate treatment plans are in place for stroke prevention. This is
especially important when trying to implement “TCD With Transfusions
Changing to Hydroxyurea (TWiTCH)” clinical trial results in the
real-world setting.